Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
Open Access
- 8 September 2020
- journal article
- review article
- Published by Elsevier BV in Acta Pharmaceutica Sinica. B
- Vol. 11 (2), 322-339
- https://doi.org/10.1016/j.apsb.2020.09.001
Abstract
No abstract availableKeywords
Funding Information
- National Center for Complementary and Integrative Health (NIH-2R15AT008277-02)
- Guangzhou Medical University (NIH-2R15AT008277-02)
- National Institutes of Health (NIH-2R15AT008277-02)
This publication has 162 references indexed in Scilit:
- Artemisinin: Discovery from the Chinese Herbal GardenCell, 2011
- Fibroblasts and Myofibroblasts: What Are We Talking About?Journal of Cardiovascular Pharmacology, 2011
- Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseasesPhytochemistry Reviews, 2010
- Non-Smad pathways in TGF-β signalingCell Research, 2008
- Regulation of scar formation by vascular endothelial growth factorLaboratory Investigation, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathwayThe Journal of cell biology, 2007
- Fibrosis and cancer: Do myofibroblasts come also from epithelial cells via EMT?Journal of Cellular Biochemistry, 2007
- A pilot study in patients with established advanced liver fibrosis using pirfenidoneGut, 2006
- Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart FailureJournal of the American College of Cardiology, 2006